New Foam Stops Internal Bleeding, Saves Crash Victim

When a patient arrived at the University of Alabama at Birmingham in critical condition after a traffic accident, doctors had a new weapon against the invisible killer: severe internal abdominal bleeding.

They injected ResQFoam, a revolutionary foam material that rapidly expands inside the abdomen to slow life-threatening blood loss. The patient's blood pressure and heart rate improved, buying precious time for lifesaving surgery.

The patient walked out of the hospital weeks later, fully recovered.

RevMedx, the U.S. company behind the innovation, designed ResQFoam to tackle one of emergency medicine's toughest challenges. When bleeding happens inside the abdomen from trauma or disease, blood loss is invisible and fast, making every second count.

The foam works by creating gentle internal pressure after injection, slowing the hemorrhage while paramedics race to get patients to operating rooms. It's the difference between arriving stable enough for surgery or not arriving at all.

Dr. Preston Huguley, who led the REVIVE clinical study at UAB, used the foam as part of the groundbreaking trial. His patient became the first success story in what could become standard emergency care.

Internal abdominal bleeding kills quickly because traditional methods to stop external bleeding don't work when you can't see or reach the source. Patients often don't survive the race to the hospital.

The Ripple Effect

This breakthrough extends far beyond one saved life. Thousands of people suffer severe abdominal trauma every year from car accidents, falls, and violent injuries.

Emergency rooms in rural areas, where transport times to trauma centers can stretch to an hour or more, could see dramatic improvements in survival rates. Military medics treating battlefield injuries could stabilize wounded soldiers in conditions where immediate surgery isn't possible.

The technology represents years of research into how to buy time when time has run out. It doesn't heal the injury, but it keeps patients alive long enough to reach the surgeons who can.

RevMedx has spent over a decade developing bleeding control technologies, and ResQFoam marks their biggest breakthrough yet. The successful clinical trial opens the door to wider testing and eventual widespread use.

For families waiting in emergency rooms, wondering if their loved one will survive the golden hour after a severe accident, this foam could mean the difference between goodbye and welcome home.